Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial.

Saved in:
Bibliographic Details
Title: Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial.
Authors: Ostendorf L; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Division of Rheumatology, Inflammation, Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Zernicke J; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Klotsche J; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany., Kempkens R; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany., Beenken AE; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Biesen R; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Cheng Q; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Khodadadi L; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Guerra GM; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany., Heinrich F; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany., Durek P; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany., Burmester GR; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Krönke G; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Hiepe F; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Mashreghi MF; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; German Center for Child and Adolescent Health (DZKJ), Berlin, Germany., Alexander T; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany. tobias.alexander@charite.de.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. tobias.alexander@charite.de.
Source: Nature communications [Nat Commun] 2026 Feb 03; Vol. 17 (1), pp. 1312. Date of Electronic Publication: 2026 Feb 03.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41629292
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ostendorf+L%22">Ostendorf L</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Division of Rheumatology, Inflammation, Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zernicke+J%22">Zernicke J</searchLink>; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Klotsche+J%22">Klotsche J</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kempkens+R%22">Kempkens R</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Beenken+AE%22">Beenken AE</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Biesen+R%22">Biesen R</searchLink>; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Cheng+Q%22">Cheng Q</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Khodadadi+L%22">Khodadadi L</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Guerra+GM%22">Guerra GM</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Heinrich+F%22">Heinrich F</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Durek+P%22">Durek P</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Burmester+GR%22">Burmester GR</searchLink>; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Krönke+G%22">Krönke G</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hiepe+F%22">Hiepe F</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Mashreghi+MF%22">Mashreghi MF</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; German Center for Child and Adolescent Health (DZKJ), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Alexander+T%22">Alexander T</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany. tobias.alexander@charite.de.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. tobias.alexander@charite.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 Feb 03; Vol. 17 (1), pp. 1312. <i>Date of Electronic Publication: </i>2026 Feb 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41629292
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-026-69112-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1312
    Titles:
      – TitleFull: Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ostendorf L
      – PersonEntity:
          Name:
            NameFull: Zernicke J
      – PersonEntity:
          Name:
            NameFull: Klotsche J
      – PersonEntity:
          Name:
            NameFull: Kempkens R
      – PersonEntity:
          Name:
            NameFull: Beenken AE
      – PersonEntity:
          Name:
            NameFull: Biesen R
      – PersonEntity:
          Name:
            NameFull: Cheng Q
      – PersonEntity:
          Name:
            NameFull: Khodadadi L
      – PersonEntity:
          Name:
            NameFull: Guerra GM
      – PersonEntity:
          Name:
            NameFull: Heinrich F
      – PersonEntity:
          Name:
            NameFull: Durek P
      – PersonEntity:
          Name:
            NameFull: Burmester GR
      – PersonEntity:
          Name:
            NameFull: Krönke G
      – PersonEntity:
          Name:
            NameFull: Hiepe F
      – PersonEntity:
          Name:
            NameFull: Mashreghi MF
      – PersonEntity:
          Name:
            NameFull: Alexander T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 02
              Text: 2026 Feb 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1